News Focus
News Focus
icon url

Maverick0408

10/18/22 4:00 PM

#522888 RE: ATLnsider #522877

“The official end of the NWBio Quiet Period. NWBio will be able to publicly and freely discuss its progress, plans and timing for DCVax-L regulatory submissions in the US, UK, Canada, Germany and the rest of the EU.”

JA does not forbid updates around regulatory submissions. They could do it now or could have done it 6-12 months ago if they wanted to. Let’s face it they haven’t updated us because there is limited progress on the applications per se given other requirements they need to fulfill first. They told us about PIP approval when progress was made. Likewise, they will tell us about commercial manufacturing approval once that comes through. Just remember - they will shout from the roof top as soon as the MAA is accepted regardless of whether the JA is out or not. And we may still be waiting for an official TLD at that point! ;)
icon url

barnstormer

10/18/22 7:58 PM

#522990 RE: ATLnsider #522877

ATL, I don't doubt the importance of the journal article, or the importance it would have in validating and verifying the DCVax-L trial results. I just doubt the article will have the significant impact on the NWBO share price that if would have if accepted and published in a shorter time frame once the initial phase 3 results were announced. Just my experience in that delays in expectations tend to minimize impact. Hope I'm wrong.